New Number One Copper Start Alert

EVs and AI devour copper. Supply cannot keep up. A Quebec discovery with high grade, infrastructure, and cheap power is funded to drill through the year. Catalysts are lining up. Institutions are circling. Move now while it is still early.

INO
Inovio Pharmaceuticals Inc
NASDAQ
2.49
Open 2.43 Prev Close 2.50
High 2.55 Low 2.41
Volume 762,097 Volume (Avg) 1,579
52 Week High 5.80 52 Week Low 1.30
Market Cap 132.6M PE Ratio

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the University of Pennsylvania, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

General

NameInovio Pharmaceuticals Inc
TickerINO
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees134

Highlights

Analyst Target7.47
Market Cap132,600,000
EBITDA-94,288,440

Share Stats

Shares Outstanding53,140,000
Shares Float52,720,000
Shares Short7,580,000
Insider Holdings51%
Institution Holdings18.95%

Highlights

Analyst Target7.47
Market Cap132,600,000
EBITDA-94,288,440

Valuation

Price/Sales (Trailing 12 Mt.)728.63
Price/Book (Most Recent Quarter)4.58

Earnings

Most Popular

Why Is Phio Pharmaceuticals Stock Soaring Today?

Shares of Phio Pharmaceuticals Corp. (NASDAQ: PHIO) are rising Monday after the company provided an update on an ongoing medical trial.

White House Insider: I've Never Shared This Story Before... - Ad

A former CIA officer with direct ties to Trump's inner circle just revealed a shocking truth about the AI arms race. This insider says Trump is about to unleash a bold move to ensure America doesn't lose - and the opportunity tied to it could be massive.

How the NFL is aiming to broaden its appeal to women

At this year’s NFL draft, some of the league’s top prospects were asked a few questions they weren’t used to.

Gold prices have tumbled from recent records. What's behind the losses?

NEW YORK (AP) — Less than a day after to another record high, prices for the precious metal plunged — marking the biggest sell-off in years.

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades

Terns Pharmaceuticals shares rise after TERN-701 shows a 75% response rate in the CML trial, and William Blair upgrades the stock to Outperform.

Why Is Rein Therapeutics Stock Trading Higher On Monday?

Rein Therapeutics shares rise after the FDA lifts clinical hold on its Phase 2 RENEW trial for idiopathic pulmonary fibrosis treatment LTI-03.

Out of 3,412 Juniors This Is the One - Ad

Only one lines up grade, scale potential, and Quebec power like this. Insider alignment is real. Stepouts are opening new zones. With EVs and grid buildouts rising, this could be the timely copper idea you have been waiting for.

Warren Buffett's Berkshire Hathaway Bets Big On Consumer Brands Amid Economic Shifts

Warren Buffett and his successor Greg Abel have been directing Berkshire Hathaway towards consumer-centric investments throughout 2025.

A Message From an Ex-Cia Officer About Trump - Ad

A former CIA officer with direct ties to Trump's inner circle just revealed a shocking truth about the AI arms race. This insider says Trump is about to unleash a bold move to ensure America doesn't lose - and the opportunity tied to it could be massive.

Wall Street Enters Its Strongest Month: These 7 Stocks Often Crush It

November is historically Wall Street's strongest month. These 7 stocks often delivered standout gains in recent decades.

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.

Coeur Mining's $7 Billion Deal For New Gold Creates $20 Billion Powerhouse

Coeur Mining Inc. (CDE) announced acquisition of New Gold Inc. (NGD) in all-stock deal valued at $7 billion.

Urgent Copper Stock With Strong Catalysts - Ad

Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.

Tanka Bets Its Memory-Native AI Platform Can Redefine How Startups Collaborate and Scale

Tanka, a U.S.-based AI collaboration platform headquatered in Bay Area, is betting on its home market with a bold premise — that the future of enterprise software will depend not on bigger models or flashier chatbots, but on memory. 

Urgent Copper Stock With Strong Catalysts - Ad

Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.

Move Over, Musk—The World's Richest Woman Joined the $100B Club

Alice Walton, daughter of Walmart founder Sam Walton, is the richest woman in the world worth more than $100 billion.

Trump's $8.5 Billion Deal With Australia Challenges Chinese Dominance

Trump and Albanese signed a partnership to secure critical mineral supply chains and strengthen defense cooperation.

Quiet Early Access Invite - Ad

We are sharing a small preview of a Quebec copper discovery with funded drilling and catalysts on deck. You will see the plan, targets, and milestones that could drive repricing as assays arrive. Early access is limited.

Tether Just Did What Bitcoin Never Could — Become The World's Shadow Central Bank

Bitcoin (CRYPTO: BTC) wanted to upend the financial system; Tether (CRYPTO: USDT) quietly built one of its own. With more than $135 billion parked in U.S.

The Smart Money Copper Trade - Ad

Pros front run catalysts. This project checks grade, jurisdiction, and runway. Polymetallic upside, expanding footprint, and steady results can attract institutions fast as copper tightens. Study this trade idea while the story is still early.

2,000 mink released from Iowa farm in what trade group calls 'terrorist act'

One or more intruders broke into an Iowa mink farm and released 2,000 of the furbearing animals in what a trade group called a “terrorist act” under federal law.

Journalists turn in access badges, exit Pentagon rather than agree to new reporting rules

WASHINGTON (AP) — Dozens of reporters turned in access badges and exited the Pentagon on Wednesday rather than agree to government-imposed , pushing journalists who cover the American military further from the seat of its power. The U.S. government has called the new rules “common sense.”

New Number One Copper Start Alert - Ad

EVs and AI devour copper. Supply cannot keep up. A Quebec discovery with high grade, infrastructure, and cheap power is funded to drill through the year. Catalysts are lining up. Institutions are circling. Move now while it is still early.

IonQ Shares Are Trading Lower Monday: What's Going On?

IonQ shares were trading higher Monday but have since reversed and began trading lower.

China EV Heat Check: Nio, Li Auto, XPeng on Fire

Nio, Li Auto and XPeng set October delivery records, powered by overseas expansion and advancing EV tech.

White House Insider: I've Never Shared This Story Before... - Ad

A former CIA officer with direct ties to Trump's inner circle just revealed a shocking truth about the AI arms race. This insider says Trump is about to unleash a bold move to ensure America doesn't lose - and the opportunity tied to it could be massive.

OpenAI's ChatGPT To Allow Erotica For Adults: Not 'Moral Police Of The World,' Sam Altman Says

OpenAI will begin allowing erotica and adult-themed content on ChatGPT, marking a major shift in the company's content policy.

Bloom Energy Stock Surges Nearly 17% In Wednesday Pre-Market: What's Going On?

Shares of Bloom Energy Corp soared 18.68% in pre-market trading on Wednesday as third-quarter results surpassed analyst estimates.

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

Dogecoin's $0.21 Problem: Why This Analyst Says Keep It On Your Radar

On Monday, social media influencer Ali Martinez, known popularly on X as Ali, drew the attention of the crypto community to an important resistance level for Dogecoin (CRYPTO: DOGE).

Trump Commutes Former Rep. George Santos' Seven-Year Prison Term: '... Has Been Horribly Mistreated'

President Donald Trump announced on Friday that he commuted the prison sentence of former congressman George Santos (R-N.Y.), ordering his immediate release.

Out of 3,412 Juniors This Is the One - Ad

Only one lines up grade, scale potential, and Quebec power like this. Insider alignment is real. Stepouts are opening new zones. With EVs and grid buildouts rising, this could be the timely copper idea you have been waiting for.

Trump's not going to the Supreme Court hearing on tariffs. But his treasury secretary will be there

WASHINGTON (AP) — President Donald Trump won't be going in person to the Supreme Court hearing Wednesday that will determine the at the heart of his economic and foreign policy -- but his treasury secretary says he will be there.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright technicaltrading.org
Privacy Policy | Terms of Service